Aspen Aerogels, Inc. filed a Current Report on Form 8-K with the Securities and Exchange Commission on September 15, 2026. The filing includes an Investor Presentation dated the same day, which provides an update on the company’s financial outlook for the third quarter of 2026. The document serves as a reference for discussions with investors, analysts, and other interested parties.
The Investor Presentation outlines the company’s proprietary aerogel technology platform, which is designed to serve energy infrastructure and electric mobility markets. The presentation highlights the company’s manufacturing footprint, which includes facilities in East Providence, Rhode Island; Marlborough and Northborough, Massachusetts; Apodaca, Mexico; and a China Aerogel External Manufacturing Facility.
Key business statistics presented include a cash and equivalents balance of $153.4 million as of June 30, 2026, and a cumulative $1.5 billion in Energy Industrial product sales. The company reports a portfolio of 400 granted patents and 430+ pending patent applications as of December 31, 2025.
The company’s Thermal Barrier segment is described as supporting blue-chip OEMs with battery thermal barrier technology at commercial scale. The presentation notes that European production is ramping in 2026, with expected revenue of $20 to $30 million, and targets $40 to $60 million of European OEM revenue in 2027. It also states that North American demand is stabilizing following a 2025 reset.
The document includes forward-looking statements regarding the company’s financial outlook for the third quarter of 2026. These statements are based on management’s current expectations and are subject to risks and uncertainties, including the execution of the growth plan, the ability to achieve expected capacity levels, and general economic conditions.
